Gammagard Liquid (human normal immunoglobulin 10%) / Takeda 
Welcome,         Profile    Billing    Logout  
 12 Diseases   6 Trials   6 Trials   125 News 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gammagard Liquid (human normal immunoglobulin 10%) / Takeda
2012-005150-34: Dose response study of intravenous immunoglobulin in CIDP

Ongoing
4
17
Europe
Solution for infusion, Kiovig
Erasmus MC, Baxter
Chronic inflammatory demyelinating polyradiculoneuropathy., nerve disorder leading to loss of muscle strnght and sensibility, Diseases [C] - Nervous System Diseases [C10]
 
 
2013-004988-32: Pharmacokinetics of IVIg treatment in patients with CIDP Farmacokinetiek van IVIg behandeling bij patiënten met CIDP

Ongoing
4
15
Europe
Kiovig, Kiovig, Kiovig
Erasmus MC, Prinses Beatrix Spierfonds
Chronic Inflammatory Demyelinating Polyneuropathy Chronische Inflammatoire Demyeliniserende Polyneuropathie
 
 
INHIBIT, NCT04302805: rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation

Completed
3
17
RoW
Privigen, IVIG, Kiovig, Thymoglobulin, rATG, Plasma Exchange, PE
Institute for Clinical and Experimental Medicine
Kidney Transplantation
04/24
06/24
IVIORDEX, NCT04968899: IgIV Plus Prednisone vs High-dose Dexamethasone for ITP

Recruiting
3
272
Europe
Neofordex®, Dexamethasone, Intravenous immunoglobulins, Tegeline®, Clayrig®,, Gammagard®,, Octagam®,, Privigen®,, Other IgIV patent medicine
Assistance Publique - Hôpitaux de Paris
Immune Thrombocytopenia (ITP)
04/25
10/26
2005-003422-26: Immunological and virological effects of high dose intravenous immunoglobulin (IVIG) treatment added to antiretroviral therapy against HIV

Ongoing
2
5
Europe
immunoglobulin, Natriumvalproat, immunoglobulin, Gammagard, Ergenyl, Gammagard, Ergenyl
Göteborg University
HIV
 
 
NCT05662228: Therapies for Down Syndrome Regression Disorder

Recruiting
2
66
US
Lorazepam, Ativan, Intravenous immunoglobulin (IVIG), Gammagard Liquid (immune globulin infusion [human] 10%), Tofacitinib, Xeljanz
University of Colorado, Denver, Children's Hospital Los Angeles
Down Syndrome, Regression
12/26
12/26
NCT05952804: IVIG for Infection Prevention After CAR-T-Cell Therapy

Recruiting
2
150
US
Immune Globulin Infusion (Human), 10% Solution, GAMMAGARD LIQUID, Anti-CD19 CAR T Cells Preparation, CD19-targeting CAR-T Cells, Saline, 7647-14-5, ISOTONIC SODIUM CHLORIDE SOLUTION, Sodium Chloride 0.9%, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Survey Administration, Electronic Health Record Review
Fred Hutchinson Cancer Center, Takeda, National Cancer Institute (NCI)
Lymphoma
07/27
07/28
NCT05363358: A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Completed
N/A
6086
US
Takeda, Baxalta Innovations GmbH, now part of Shire, RTI Health Solutions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
12/22
12/22

Download Options